Loading data for APYX — first visit, this takes a few seconds.

알림

Apyx Medical Corporation (APYX)

NasdaqGS: APYX · 실시간 가격 · USD

3.12

+0.09 (2.97%)

종가 기준: Aug 21, 2026, 8:00 PM

3.12

+0.00%

애프터마켓: 7:30 PM

주가와 핵심 숫자, 최신 뉴스를 한 곳에 모았습니다.

2.97% (1D)

데이터 없음

매수호가	n/a
시가총액	131.43M
매출 (ttm)	58.41M
순이익 (ttm)	-8.63M
	1.35
	-0.2
	n/a
	-12.09
P/B (ttm)	12.33
P/S (ttm)	2.25
실적 발표일	Nov 5, 2026

매도호가	n/a
거래량	52,579
평균 거래량 (20일)	122,885
시가	3.05
전일 종가	3.03
일중 범위	3.04 - 3.17
52주 범위	1.70 - 5.08
애널리스트	n/a
목표주가	n/a
배당	n/a
배당락일	n/a

APYX 소개

Apyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally. The company operates through two segments: Surgical Aesthetics and Original Equipment Manufacturing (OEM). It offers helium plasma generator for the delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasi...

[더 보기]

산업 Medical Devices

섹터 Healthcare

IPO 일자 Jan 2, 2019

직원 수 205

상장 거래소 NasdaqGS

티커 APYX

웹사이트 https://apyxmedical.com

전체 기업 정보

재무 실적

2025년 Apyx Medical의 매출은 52.84M로, 전년 48.1M 대비 9.86% 증가했습니다. 순이익은 -11.21M로, -52.22% 감소했습니다.

재무제표

어닝 서프라이즈

Apyx Medical가 Aug 6, 2026에 분기 실적을 발표했습니다:

매출 $13.88M 예상치 하회 $0, 및 22.08% 전년 대비 성장.
EPS -0.07 예상치 상회 0.01, 및 22.22% 전년 대비 성장.

다음 실적 발표

Apyx Medical Corporation의 실적 발표 예정일은 Nov 5, 2026, 정규장 중입니다.
애널리스트 예상 매출은 ... 업그레이드

뉴스

1주 전 · Motley Fool

Apyx Medical (APYX) Q2 2026 Earnings Call Transcript

AYON adoption accelerated 22% as surgeons target GLP-1 weight-loss patients.

1주 전 · MarketBeat

Apyx Medical Sees GLP-1 Boom Fueling Demand for Renuvion, AYON Body Contouring

Apyx Medical (NASDAQ:APYX) is positioning its Renuvion technology and newly launched AYON Body Contouring System to address growing demand for surgical aesthetic procedures, a trend CEO Charlie Goodwi...

2주 전 · GuruFocus.com

Apyx Medical Corp (APYX) (Q2 2026) Earnings Call Highlights: Revenue Surges 22% on Power Lipo ...

Company capitalizes on expanded FDA clearance and growing body contouring demand, reaffirming full-year guidance despite margin headwinds.

2주 전 · Zacks

Apyx Medical (APYX) Reports Q2 Loss, Beats Revenue Estimates

Apyx (APYX) delivered earnings and revenue surprises of -16.67% and +10.37%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

2주 전 · MarketBeat

Apyx Medical Q2 Earnings Call Highlights

Apyx Medical (NASDAQ:APYX) reported second-quarter revenue growth of 22% as sales in its surgical aesthetics business increased, led by adoption of its AYON Body Contouring System, international gener...

2 페이지 중 1

Apyx Medical Corporation (APYX)